Dr. Simonson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
221 Longwood Ave
# Brigham
Boston, MA 02115Phone+1 617-732-7672Fax+1 617-277-1568
Summary
- Dr. Donald Simonson is an endocrinologist based in Boston, MA, specializing in diabetes and lipid metabolism. He completed his medical training at Yale School of Medicine, followed by residencies in internal medicine at MedStar Health/Georgetown University Hospital and Yale-New Haven Medical Center, and a fellowship in endocrinology, diabetes, and metabolism at Yale-New Haven Medical Center. He has been on the faculty at Harvard Medical School since 1987, and previously served as Head of the Section of Clinical Physiology at Joslin Diabetes Center and Chief of the Section of Diabetes and Metabolism at Brigham and Women's Hospital. He has authored several publications, including studies on post-bariatric hypoglycemia and metabolic surgery outcomes. Dr. Simonson was elected a member of The American Society for Clinical Investigation in 1996.
Education & Training
- Yale-New Haven Medical CenterResidency, Internal Medicine, 1982 - 1983
- Yale-New Haven Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1980 - 1982
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1978 - 1980
- Yale School of MedicineClass of 1978
Certifications & Licensure
- MA State Medical License 1987 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1996
Publications & Presentations
PubMed
- Health-Related Quality of Life and Health Utility After Metabolic/Bariatric Surgery Versus Medical/Lifestyle Intervention in Individuals With Type 2 Diabetes and Obesi...Donald C Simonson, William F Gourash, David E Arterburn, Bo Hu, Sangeeta R Kashyap
Diabetes Care. 2025-02-04 - Defining Clinical Characteristics of Individuals With and Without Post-Bariatric Hypoglycemia After Gastric Bypass.Ashna Grover, Maryam Farahmandsadr, Hamayle Saeed, Cameron Cummings, Amanda Sheehan
Clinical Endocrinology. 2025-02-01 - 1 citationsLong-term outcomes of metabolic surgery versus medical/lifestyle therapy on metabolic dysfunction-associated fatty liver disease in adults with obesity and type 2 diab...Michelle D Lundholm, Sarah Kirschling, Bo Hu, Ali Aminian, David E Arterburn
Diabetes, Obesity & Metabolism. 2024-12-01
Press Mentions
- Bariatric Surgery, Intensive Weight Management Comparable in Type 2 DiabetesMarch 11th, 2015
- High Blood Sugar Causes Brain Changes That Raise Depression RiskJune 23rd, 2014
- New Findings from ARMMS-T2D Study Continue to Show Benefits of metabolic/bariatric Surgery over Medical Interventions for Those with Type 2 DiabetesJune 25th, 2024
Grant Support
- Effect Of Hyperglycemia On Renal FunctionNational Center For Research Resources1992–1994
- Sodium Regulation And Response To Angiotensin II In IDDMNational Institute Of Diabetes And Digestive And Kidney Diseases1991–1994
- Mechanism Of Metabolic Changes During Intensive Insulin TherapyNational Center For Research Resources1991–1993
- Role Of Angiotensin In Diabetic Renal DiseaseNational Center For Research Resources1992
- Cytosolic Calcium, Insulin-Resistance And Non-ModulationNational Center For Research Resources1991–1992
- Serca-Diabetes Mellitus In The ElderlyNational Institute On Aging1987
- Serca-Diabetes Mellitus In The ElderlyNational Institute On Aging1985–1986
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: